Clinical Trial Detail

NCT ID NCT03318900
Title T Cell Immunotherapy for Advanced Ovarian Cancer
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

ovary epithelial cancer

Therapies

Aldesleukin + Cyclophosphamide + Utomilumab

Age Groups: adult senior

No variant requirements are available.